Generation of iVero.219-mcRTA: a doxycycline-inducible high-titer KSHV producer cell line with multicopy orf50 integration
Frontiers in Cellular and Infection Microbiology · 13.04.2026 · 16
DOI: 10.3389/fcimb.2026.1760149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 13.04.2026. Verfasst von Li Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: TEDA Institute of Biological Sciences and Biotechnology, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Doxycycline, Trans-Activators, Virus Integration. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Tianjin Municipality.
Abstract (Originalsprache)
Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic virus whose reactivation from latency to lytic replication is orchestrated by the replication and transcription activator (RTA) encoded by orf50 . Doxycycline (DOX)-inducible RTA expression is commonly used in engineered cellular models to trigger this reactivation and produce infectious virus. However, this approach often requires co-treatment with histone deacetylase inhibitors (HDACi), such as sodium butyrate (SB), whose pleiotropic epigenetic effects can obscure experimental interpretation. To address this limitation, we generated the iVero.219-mcRTA polyclonal cell line by sequential lentiviral transduction using vectors with distinct antibiotic selection markers, achieving stable multicopy integration of the inducible RTA cassette, with total copy number reaching approximately 150 per cell as determined by droplet digital PCR. Upon DOX induction alone, 51.6% of cells expressed RFP, indicating efficient reactivation. qPCR quantification of viral DNA in the supernatant showed (5.7 ± 0.1) × 10 4 genome copies/mL, and infection assays in 293T cells yielded an infectious titer of (2.4 ± 0.1) × 10 4 IU/mL based on Poisson distribution analysis of serial dilutions. Supplementation with SB enhanced these values to (1.5 ± 0.1) × 10 5 genome copies/mL and (7.5 ± 0.2) × 10 4 IU/mL, respectively. Notably, the supernatant induced with DOX alone, once concentrated, achieved an infectious titer of (2.1 ± 0.1) × 10 5 IU/mL, without the need for HDACi. Collectively, the iVero.219-mcRTA system enables robust, high-titer KSHV production using DOX alone, providing a simplified and HDACi-independent tool that will facilitate future KSHV research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- TEDA Institute of Biological Sciences and Biotechnology, Nankai University, Tianjin, China.
- Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, Tianjin, China.
- Tianjin Key Laboratory of Microbial Functional Genomics, Tianjin, China.
Förderung
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Wang, L., Wang, X., Chen, Q., Wu, J., Xu, Y., Wang, J., & Wang, Y. (2026). Generation of iVero.219-mcRTA: a doxycycline-inducible high-titer KSHV producer cell line with multicopy orf50 integration. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1760149
Vancouver
Wang L, Wang X, Chen Q, Wu J, Xu Y, Wang J, et al. Generation of iVero.219-mcRTA: a doxycycline-inducible high-titer KSHV producer cell line with multicopy orf50 integration. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1760149
BibTeX
@article{Wang2026,
author = {Wang, Li and Wang, Xueli and Chen, Qiyan and Wu, Junli and Xu, Yanli and Wang, Jinzhong and Wang, Ying},
title = {Generation of iVero.219-mcRTA: a doxycycline-inducible high-titer KSHV producer cell line with multicopy orf50 integration},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1760149}
}
EUVIMED